124 related articles for article (PubMed ID: 32095324)
1. Prognostic analysis of very early onset pancreatic cancer: a population-based analysis.
Dai D; Wang Y; Hu X; Jin H; Wang X
PeerJ; 2020; 8():e8412. PubMed ID: 32095324
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of KRAS mutation status in colorectal cancer patients: a population-based competing risk analysis.
Dai D; Wang Y; Zhu L; Jin H; Wang X
PeerJ; 2020; 8():e9149. PubMed ID: 32547859
[TBL] [Abstract][Full Text] [Related]
3. Nomogram for predicting survival in patients with pancreatic cancer.
Song W; Miao DL; Chen L
Onco Targets Ther; 2018; 11():539-545. PubMed ID: 29416354
[TBL] [Abstract][Full Text] [Related]
4. A Competing-Risks Nomogram in Patients with Metastatic Pancreatic Duct Adenocarcinoma.
Lu Y; Zhou Y; Cao Y; Shi Z; Meng Q
Med Sci Monit; 2019 May; 25():3683-3691. PubMed ID: 31102397
[TBL] [Abstract][Full Text] [Related]
5. Nomogram to predict cause-specific mortality of patients with rectal adenocarcinoma undergoing surgery: a competing risk analysis.
Zhang X; Xu F; Bin Y; Liu T; Li Z; Guo D; Li Y; Huang Q; Lyu J; He S
BMC Gastroenterol; 2022 Feb; 22(1):57. PubMed ID: 35144545
[TBL] [Abstract][Full Text] [Related]
6. Very Early Onset Pancreatic Adenocarcinoma - Clinical Presentation, Risk Factors and Therapeutic Options.
Bunduc Ș; Iacob R; Costache R; Stoica B; Radu C; Gheorghe C
Chirurgia (Bucur); 2018; 113(3):405-411. PubMed ID: 29981672
[No Abstract] [Full Text] [Related]
7. Nomogram predicting cancer-specific mortality in early-onset rectal cancer: a competing risk analysis.
Wang Y; Wu J; He H; Ma H; Hu L; Wen J; Lyu J
Int J Colorectal Dis; 2020 May; 35(5):795-804. PubMed ID: 32078716
[TBL] [Abstract][Full Text] [Related]
8. Nomogram Predicting Cancer-Specific Death in Parotid Carcinoma: a Competing Risk Analysis.
Li X; Hu M; Gu W; Liu D; Mei J; Chen S
Front Oncol; 2021; 11():698870. PubMed ID: 34722245
[TBL] [Abstract][Full Text] [Related]
9. A competing-risk nomogram to predict cause-specific death in elderly patients with colorectal cancer after surgery (especially for colon cancer).
Wang Z; Wang Y; Yang Y; Luo Y; Liu J; Xu Y; Liu X
World J Surg Oncol; 2020 Feb; 18(1):30. PubMed ID: 32019568
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of nomograms for predicting survival of elderly patients with stage I small-cell lung cancer.
Yang Y; Sun S; Wang Y; Xiong F; Xiao Y; Huang J
Bosn J Basic Med Sci; 2021 Oct; 21(5):632-641. PubMed ID: 33577444
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a competing risk model for second primary pancreatic ductal adenocarcinoma: A population-based study.
Song L; Xu C; Zhang T; Chen S; Shi Z; Hu S; Cheng B; Tong H; Wei G; Li X
Front Surg; 2022; 9():934148. PubMed ID: 36111234
[TBL] [Abstract][Full Text] [Related]
12. A competing risk nomogram for predicting cancer-specific death of patients with buccal mucosa cancer.
Jiang Q; Xue D; Xin Y; Qiu J
Oral Dis; 2021 May; 27(4):900-910. PubMed ID: 32791562
[TBL] [Abstract][Full Text] [Related]
13. Effects of Total Pancreatectomy on Survival of Patients With Pancreatic Ductal Adenocarcinoma: A Population-Based Study.
Shao W; Lu Z; Xu J; Shi X; Tan T; Xing C; Song J
Front Surg; 2021; 8():804785. PubMed ID: 34957210
[No Abstract] [Full Text] [Related]
14. Development and validation of a prognostic model to predict the prognosis of patients who underwent chemotherapy and resection of pancreatic adenocarcinoma: a large international population-based cohort study.
Huang L; Balavarca Y; van der Geest L; Lemmens V; Van Eycken L; De Schutter H; Johannesen TB; Zadnik V; Primic-Žakelj M; Mägi M; Grützmann R; Besselink MG; Schrotz-King P; Brenner H; Jansen L
BMC Med; 2019 Mar; 17(1):66. PubMed ID: 30905320
[TBL] [Abstract][Full Text] [Related]
15. Competing-risk nomogram for predicting survival in patients with advanced (stage III/IV) gallbladder cancer: A SEER population-based study.
Wang J; Yang Y; Pan J; Qiu Y; Shen S; Wang W
Jpn J Clin Oncol; 2022 Apr; 52(4):353-361. PubMed ID: 35137118
[TBL] [Abstract][Full Text] [Related]
16. Competing risk nomogram predicting cancer-specific mortality for endometrial cancer patients treated with hysterectomy.
Xie G; Qi C; Yang W; Wang R; Yang L; Shang L; Huang L; Chung MC
Cancer Med; 2021 May; 10(10):3205-3213. PubMed ID: 33932121
[TBL] [Abstract][Full Text] [Related]
17. Establishment of a Competing Risk Nomogram in Patients with Pulmonary Sarcomatoid Carcinoma.
Liang Z; Zhang E; Duan L; Weygant N; An G; Hu B; Yao J
Technol Cancer Res Treat; 2022; 21():15330338211068960. PubMed ID: 35179409
[No Abstract] [Full Text] [Related]
18. A nomogram predicting overall survival in patients with non-metastatic pancreatic head adenocarcinoma after surgery: a population-based study.
Zou W; Wang Z; Wang F; Zhang G; Liu R
BMC Cancer; 2021 May; 21(1):524. PubMed ID: 33964898
[TBL] [Abstract][Full Text] [Related]
19. Predicting Cancer-Specific Survival Among Patients With Prostate Cancer After Radical Prostatectomy Based on the Competing Risk Model: Population-Based Study.
Zhou X; Qiu S; Jin K; Yuan Q; Jin D; Zhang Z; Zheng X; Li J; Wei Q; Yang L
Front Surg; 2021; 8():770169. PubMed ID: 34901145
[No Abstract] [Full Text] [Related]
20. A prognostic model of patients with ovarian mucinous adenocarcinoma: a population-based analysis.
Yang L; Yu J; Zhang S; Shan Y; Li Y; Xu L; Zhang J; Zhang J
J Ovarian Res; 2022 Feb; 15(1):26. PubMed ID: 35168642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
